Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7.70%-441.13K | 26.75%-78.66K | -25.74%-200.47K | 39.94%-676.13K | 100.17%262 | -42.73%-409.57K | 63.97%-107.39K | 58.45%-159.43K | 24.90%-1.13M | 69.40%-157.15K |
| Net income from continuing operations | -240.61%-795.95K | 45.40%-121.97K | 62.67%-188.53K | 17.71%-1.18M | 37.88%-219.08K | 34.04%-233.69K | 32.05%-223.39K | -26.34%-505.1K | 70.45%-1.44M | 47.63%-352.68K |
| Operating gains losses | ---755 | ---757 | ---740 | --3.15K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 11.27%8.71K | 11.25%8.71K | 11.28%8.71K | -8.78%32.06K | 9.62%8.58K | 0.00%7.83K | 0.01%7.83K | -32.91%7.83K | 7.64%35.15K | -56.31%7.83K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.57K | ---- |
| Remuneration paid in stock | 1,133.68%476.95K | -99.14%645 | -95.43%10.8K | 218.29%347.54K | -104.96%-2.58K | -19.59%38.66K | 44,727.38%74.97K | 2,461.85%236.48K | -83.07%109.19K | -56.14%52.05K |
| Other non cashItems | -0.30%11.9K | 1.61%11.97K | -24.73%8.65K | 52.82%44.4K | 161.35%9.2K | 3.29%11.93K | -22.73%11.78K | -33.39%11.49K | -98.83%29.06K | 94.66%-15K |
| Change In working capital | 39.40%-141.98K | 6.19%22.74K | -143.79%-39.36K | -42.15%77.98K | 34.82%200.99K | -257,375.82%-234.3K | 173.28%21.42K | 507.88%89.87K | -31.49%134.79K | -47.49%149.08K |
| -Change in receivables | -240.27%-317 | -100.01%-2 | 144.25%9.38K | -160.30%-21.03K | -348.76%-16.12K | -97.79%226 | -63.28%16.06K | -36.72%-21.19K | 173.82%34.88K | 94.56%-3.59K |
| -Change in inventory | 17.15%9.34K | -63.26%6.13K | -585.94%-22.67K | -60.20%45.16K | -69.54%15.84K | -33.23%7.97K | -42.65%16.68K | -77.15%4.67K | 232.06%113.44K | 147.24%52K |
| -Change in prepaid assets | 52.04%-54.06K | 137.25%3.96K | 1,650.92%39.53K | -201.05%-19.02K | 2,620.63%94.57K | -1,243.00%-112.71K | -75.73%1.67K | -84.71%-2.55K | -91.04%18.83K | -98.41%3.48K |
| -Change in payables and accrued expense | 25.31%-96.94K | 3,173.30%12.66K | -138.72%-51.67K | 140.18%153.93K | 53.85%150.69K | -286.91%-129.79K | 99.51%-412 | 60.32%133.44K | -31.93%64.09K | -54.54%97.95K |
| -Change in other working capital | --0 | --0 | 43.14%-13.92K | 15.97%-81.05K | -5,756.72%-43.98K | --0 | -207.50%-12.57K | 77.49%-24.49K | -475.36%-96.45K | ---751 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7.70%-441.13K | 26.75%-78.66K | -25.74%-200.47K | 39.94%-676.13K | 100.17%262 | -42.73%-409.57K | 63.97%-107.39K | 58.45%-159.43K | 24.90%-1.13M | 69.40%-157.15K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -7.06K | 0 | ||||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---3.96K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---3.1K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---7.06K | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 407.15%2.13M | -73.94%56K | -100.73%-1.27K | 196.69%886.92K | 4,142.05%79.31K | 37.42%420.04K | 214.92K | 3,734.84%172.66K | -87.72%298.94K | -103.68%-1.96K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -626.06%-137.95K | --0 |
| Net common stock issuance | 190.33%1.84M | --0 | 3.53%103.53K | 55.77%738.08K | ---25K | 33.61%633.08K | --30K | --100K | -81.38%473.82K | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --362.5K | --56K | --0 | --73.17K | --0 | --0 | --0 | --73.17K | --0 | --0 |
| Interest paid (cash flow from financing activities) | --0 | --0 | --0 | --0 | 102.40%2.02K | 97.77%-757 | ---755 | ---510 | ---32.96K | --999 |
| Net other financing activities | 90.42%-20.34K | --0 | ---104.79K | 2,010.45%75.67K | 3,554.34%102.28K | ---212.28K | ---- | ---- | 95.66%-3.96K | -105.10%-2.96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 407.15%2.13M | -73.94%56K | -100.73%-1.27K | 196.69%886.92K | 4,142.05%79.31K | 37.42%420.04K | --214.92K | 3,734.84%172.66K | -87.72%298.94K | -103.68%-1.96K |
| Net cash flow | ||||||||||
| Beginning cash position | -55.97%111.23K | -7.74%133.89K | 154.46%335.63K | -86.24%131.9K | -9.58%263.12K | -7.22%252.65K | -74.55%145.12K | -86.24%131.9K | 451.36%958.76K | -79.49%291.01K |
| Current changes in cash | 16,035.57%1.69M | -121.07%-22.66K | -1,625.34%-201.74K | 124.64%203.73K | 145.57%72.51K | -44.05%10.47K | 136.08%107.53K | 103.40%13.23K | -205.35%-826.86K | 65.42%-159.11K |
| End cash Position | 584.21%1.8M | -55.97%111.23K | -7.74%133.89K | 154.46%335.63K | 154.46%335.63K | -9.58%263.12K | -7.22%252.65K | -74.55%145.12K | -86.24%131.9K | -86.24%131.9K |
| Free cash from | -7.70%-441.13K | 26.75%-78.66K | -25.74%-200.47K | 39.32%-683.18K | 95.68%-6.8K | -42.73%-409.57K | 63.97%-107.39K | 58.45%-159.43K | 31.74%-1.13M | 69.40%-157.15K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.